HOUSE OF REPRESENTATIVES
THE TWENTY-SECOND LEGISLATURE
REGULAR SESSION OF 2004
COMMITTEE ON HEALTH |
Rep. Dennis A. Arakaki, Chair |
Rep. Scott Y. Nishimoto, Vice Chair |
Rep. Helene H. Hale |
Rep. Corinne W.L. Ching |
Rep. Michael Puamamo Kahikina |
Rep. Lynn Finnegan |
Rep. Maile S.L. Shimabukuro |
Rep. Bud Stonebraker |
COMMITTEE ON HUMAN SERVICES AND HOUSING |
Rep. Michael Puamamo Kahikina, Chair |
Rep. Maile S.L. Shimabukuro, Vice Chair |
Rep. Dennis A. Arakaki |
Rep. Corinne W.L. Ching |
Rep. Helène H. Hale |
Rep. Lynn Finnegan |
Rep. Bertha C. Kawakami |
Rep. Bud Stonebraker |
Rep. Scott Y. Nishimoto |
NOTICE OF INFORMATIONAL BRIEFING
DATE: |
Thursday, April 8, 2004 |
TIME: |
9:00 a.m. to 12:00 noon (break) to reconvene at 1:00 p.m. to 3:30 p.m. |
PLACE: |
Auditorium State Capitol 415 South Beretania Street |
A G E N D A
The purpose of this Joint Informational Briefing is to discuss the prevention, education, intervention, and treatment of Crystal Methamphetamine (Crystal Meth or Ice). In addition, the panel will focus on community funding for programs dealing with Crystal Meth users and its effects on the person. The panel of speakers will consist of Nationally recognized experts on Crystal Meth and will also provide information on HB 2004, HD1, SD1 and SB3234, SD1.
The Hosts for this informational briefing are Rep. Arakaki, Rep. Michael P. Kahikina, and Allison Colker, Esq., National Conference of State Legislators.
Our Guest Speakers are:
Linda M. Rosen, M.D., Deputy Director, Department of Health, Health Resources Administration
DOH's Perspective on Hawaii's Ice Epidemic
Sherry Franklin, Director for Integrated Services, HMSA
Drug Prevention in the workplace
The Honorable Lieutenant Governor James "Duke" Aiona
Hawaii's Drug Control Strategy, Mission, and Goals
Darryl Inaba, Pharm. D., Haight Ashbury Free Clinics
Pharmacology of Crystal Meth and its Effect on the Addict, Current Policy on Crystal Meth and Treatment
Richard Rawson, Ph.D., UCLA Integrated Substance Abuse Programs; Principal Investigator
Methamphetamine Clinical Trials Group (UCLA/National Institute of Drug Abuse)
Extent of the Methamphetamine Epidemic and Elements of Successful Treatment for Methamphetamine Disorders
Andy Anderson, Director, CEO, Hina Mauka
Community Intervention and the Commercial Aspects of Treatment: Present Sources of Funding and Financial Obstacles to Treating the Addict
William Haning, M.D., Addiction Program Director (Psychiatry) and Associate Dean, University of Hawaii John A. Burns School of Medicine
Directions Provided by Research and Implications for Policy: The Public Health View of Methamphetamine Dependence
A LIGHT LUNCH WILL BE PROVIDED IN ROOM 329, BETWEEN 12 NOON TO 1:00 P.M., TO THE SPEAKERS, LEGISLATORS, PARTICIPANTS, AUDIENCE, LEGISLATIVE SUPPORT STAFF AND SARGENT AT ARMS SUPPORT STAFF. PLEASE NOTE, QUESTIONS AND ANSWERS ARE ENCOURAGED DURING THE LUNCH BREAK.
IF YOU REQUIRE SPECIAL ASSISTANCE OR AUXILIARY AIDS AND/OR SERVICES TO PARTICIPATE IN THE PUBLIC HEARING PROCESS OF THE STATE HOUSE (I.E., SIGN LANGUAGE INTERPRETER, WHEELCHAIR ACCESSIBILITY, OR PARKING DESIGNATED FOR THE DISABLED), PLEASE CONTACT THE COMMITTEE CLERK AT LEAST 24 HOURS PRIOR TO THE HEARING SO ARRANGEMENTS CAN BE MADE.
FOR FURTHER INFORMATION, PLEASE CALL THE COMMITTEE CLERK AT 586-6050.
________________________________________ Rep. Dennis A. Arakaki Chair |
________________________________________ Rep. Michael P. Kahikina Chair |
|